Abstract
This study employs time-kill techniques to examine the most common drug combinations used in the therapy of methicillin-resistant Staphylococcus aureus (MRSA) infections, vancomycin plus either gentamicin or rifampin. Community-associated MRSA were more likely to be synergistically inhibited by combinations of vancomycin and gentamicin versus vancomycin alone compared to inhibition associated with hospital-acquired strains.
Original language | English (US) |
---|---|
Pages (from-to) | 4016-4019 |
Number of pages | 4 |
Journal | Antimicrobial Agents and Chemotherapy |
Volume | 48 |
Issue number | 10 |
DOIs | |
State | Published - Oct 2004 |
ASJC Scopus subject areas
- Pharmacology
- Pharmacology (medical)
- Infectious Diseases